BANK VONTOBEL/CALL/MERCK & CO./140/0.1/20.12.24 | Market Closed - Bid/Ask 14:06:03 2024-06-13 EDT | ||
| 0.34 EUR | -10.53% |
|
| Current month | +35.71% | ||
| 1 month | -13.64% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 24-06-13 | 0.34 | -10.53% |
| 24-06-12 | 0.38 | -9.52% |
| 24-06-11 | 0.42 | +2.44% |
| 24-06-10 | 0.41 | +5.13% |
| 24-06-07 | 0.39 | +8.33% |
Real-time Boerse Frankfurt Warrants
Last update June 13, 2024 at 02:06 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
Vontobel
|
| WKN | VD3SE2 |
| ISIN | DE000VD3SE22 |
| Date issued | 2024-04-09 |
| Strike | 140 $ |
| Maturity | 2024-12-20 (190 Days) |
| Parity | 10 : 1 |
| Emission price | 0.41 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.57 € |
|---|---|
| Lowest since issue | 0.28 € |
| Spread | 0.01 € |
| Spread % | 2.86% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.2
USD
Average target price
142.7
USD
Spread / Average Target
+9.59%
- Stock Market
- Warrants
- Warrant
